NTI publishes its proof-of-principle studies in Clinical Chemistry, demonstrating utility of its ALEX single molecule detection technology for clinical molecular diagnostics applications (Yim, et al., Four-Color Alternating-Laser Excitation Single-Molecule Fluorescence Spectroscopy for Next-Generation Biodetection Assays. Clinical Chemistry 58, 707-16 (2012)).